Tranexamic acid use linked to decreased incidence of heterotopic ossification after elbow trauma surgery

FHS
June 22, 2023
2:57 pm

For patients undergoing surgery for elbow trauma, treatment with the hemostatic drug tranexamic acid (TXA) is associated with a decreased incidence of heterotopic ossification (HO) – a common complication of abnormal bone formation, reports a study in The Journal of Bone & Joint Surgery.

Trailing Novartis and Eli Lilly, radiopharmaceuticals startup Full-Life Technologies nabs $63M to test new PSMA drug

As the US radiopharmaceutical space heats up with the acquisitions of RayzeBio and Point Biopharma, a younger startup based out of China and Belgium has

January 4, 2024

Could vitamin D be the missing link in managing type 2 diabetes? Recent study weighs in

Vitamin D’s role in type 2 diabetes management is evolving, with evidence suggesting it may improve blood sugar levels and reduce diabetes-related inflammation.

October 29, 2024

Balance on one leg may be the best indicator of neuromuscular aging, new study suggests

Aging significantly affects unipedal balance and strength, highlighting the need for targeted interventions to address neuromuscular decline in older adults.

October 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.